Table 1. Clinical characteristics of the patients.
| Characteristics | Control subjects | Hypertensive subjects | Left ventricular hypertrophy hypertensive subjects | P value |
|---|---|---|---|---|
| n | 23 | 28 | 8 | |
| Age (years) | >46.8±4.7 | >52.8±9.6 | >57.6±2.5 | 0.12 |
| SBP (mmHg) | >106.6±5.7 | >126.6±5.7 | >123.3±5.8 | 0.0005* |
| DBP (mmHg) | >70±10 | >83.3±5.7 | >86.3±5.7 | 0.07 |
| LV mass index (g/m2) | >55.8±10.2 | >61.8±9.1 | >158.5±67.9 | <0.0001* |
| LV wall thickness (mm) | >9.33±0.57 | >8.88±0.83 | >13.0±1.88 | 0.0002* |
| LV dimension (mm) | >31.3±4.6 | >32.2±2.8 | >38.2±3.11 | 0.01* |
| Ejection fraction (%) | >74.6±5.5 | >71.2±6.9 | >69.3±5.6 | 0.5 |
| Glucose (mg/dL) | >79.3±13 | >88.2±11.4 | >88.6±5.2 | 0.14 |
| Creatinine (mg/dL) | >0.75±0.14 | >0.87±0.15 | >0.80±0.2 | 0.23 |
| Uric acid (mg/dL) | >4.26±1.8 | >4.27±0.5 | >3.9±0.7 | 0.83 |
| Current smoker (N) | 2 | 2 | 3 | |
| Medication | ||||
| ACEI/ARBs (%) | 75 | 100 | ||
| B-blockers (%) | 25 | 20 | ||
| Diuretic (%) | 25 | 25 | ||
SBP: systolic blood pressure; DBP: diastolic blood pressure; LV: left ventricular; ACEI: angiotensin converting enzyme inhibitor; ARB: angiotensin receptor blocker.
*
P<0.05.